公司上市与融资 - Medline完成了超过四年来最大规模的首次公开募股 其IPO融资规模高达62.6亿美元[1] 公司业务与商业模式 - 公司是医疗外科产品和医疗行业供应链解决方案的最大供应商[1] - 公司收入构成均衡 一半来自销售自有品牌Medline的医疗外科产品 另一半来自为医疗行业提供供应链解决方案[2] - 公司绝大部分利润来源于产品销售业务[2] - 供应链业务使公司能够洞察医院需求并帮助其销售自有产品[2] - 公司CEO将其商业模式比喻为“医疗保健领域的Costco” 采用会员制模式并通过供应链业务为医疗提供商提供最优价格[3] - 公司的自有品牌Medline产品类似于Costco的Kirkland Signature品牌 作为优质自有品牌其利润率远高于其他经销商品[3][4] 公司财务表现 - 公司近年来收入增长稳健且呈加速趋势 2023年增长8.3% 2024年增长9.8% 2025年前9个月增长10.3%[4]

And right now we are 2 minutes away from the end of the trading day. Romaine Bostick alongside Katie Greifeld, taking you through to that closing bell with a global simulcast. We're joined now by Carol Massar and Tim Stenovec from the radio room.Welcome to our audiences across all of our Bloomberg platforms, including our partnership with YouTube. A decidedly down day. Stocks at session lows right now as we get just less than 2 minutes to those bells and Carol Massar, we're going to close below some key mov ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s 2021 listing, capping a strong year for new listings and fueling optimism for 2026.Shares of the company opened at $35, compared with its IPO price of $29 per share. The stock closed at $41.The medical supplies maker and distributor — acquired for $34 billion in 2021 by Blackstone, Carlyle and Hellman & Friedman i ...

The IPO of the year, the biggest one, uh, popping on its open last hours, just a few minutes ago, really after some middling performance in the IPO market generally. Is it a sign of pent-up demand into mega offerings like SpaceX next year. A sigh of relief for the private equity space, too.Leslie Picker has more over at the NASDAQ. Leslie, hey, Kelly, [music] yes. The largest IPO of the year, Medline, opening for trading about 15 minutes ago at $35 per share.That's up more than 20% from its IPO price of $29 ...

Key Takeaways Shares of medical supply company Medline soared in their trading debut on the Nasdaq Wednesday.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline shares surged in their trading debut Wednesday, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The stock, which trades under the "MDLN" stock tic ...

Shares of Medline opened 20.7% above their offer price in their Nasdaq debut on Wednesday, giving the medical supply giant a valuation of $46.03 billion. ...

Key Takeaways Medical supply company Medline is set to make its trading debut on the Nasdaq today.The company raised more than $6 billion with the sale of 216 million shares priced at $29 each, making its the largest U.S. IPO in terms of proceeds since Rivian's in 2021. Medline is set to start trading on the Nasdaq today, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.  The medical supply giant, which will debut under the "MDLN" stoc ...

Medline Inc. shares are indicated to open 16% above their initial public offering price, after the medical supplier raised $6.26 billion in the year’s biggest listing. The shares are indicated at $33.50 each, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. Most Read from Bloomberg Medline manufactures and distributes medical supp ...

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year. The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the IPO market in 2026. Shares of Medline will trade under the symbol "MDLN." The IPO pricing gives Medline a market value of at least $37 billion, based on the shares listed in its regul ...

It's been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump's Liberation Day tariffs in the spring, followed by the longest U.S. government shutdown in history this fall. That's on top of an economy already hit hard by inflation and declining consumer confidence. Yet despite this, there have still been several high-profile and successful initial public offerings throughout the year—especially in the AI and fintech s ...